FDA challenges stem cell companies as patients run out of time
February 4, 2013
While patients in dire situations are willing to try the therapy (and pay the hefty costs), there’s concern the research doesn’t support broad practice just yet. (NPR)
February 4, 2013
While patients in dire situations are willing to try the therapy (and pay the hefty costs), there’s concern the research doesn’t support broad practice just yet. (NPR)